Johanna Mercier - Jul 24, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Commercial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Johanna Mercier
Stock symbol
GILD
Transactions as of
Jul 24, 2023
Transactions value $
-$246,493
Form type
4
Date filed
7/25/2023, 06:15 PM
Previous filing
Jun 12, 2023
Next filing
Sep 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +7.51K +17.06% 51.5K Jul 24, 2023 Direct F1
transaction GILD Common Stock Tax liability -$246K -3.17K -6.16% $77.66 48.3K Jul 24, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -7.51K -14.17% 45.4K Jul 24, 2023 Common Stock 7.51K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the yearly anniversary of the date of grant until fully vested.